참고문헌
- Anastasiadis A, de Reijke TM. Best practice in the treatment of nonmuscle invasive bladder cancer. Ther Adv Urol 2012;4(1): 13-32. https://doi.org/10.1177/1756287211431976
- National Cancer Institute. Cancer stat facts: bladder cancer [cited 2017 Nov 20]. Available from: https://seer.cancer.gov/statfacts/html/urinb.html.
- American Cancer Society. Survival rates for bladder cancer [cited 2018 Jan 3]. Available from: https://www.cancer.org/cancer/bladder-cancer/detection-diagnosis-staging/survival-rates.html.
- Cheng L, MacLennan GT, Lopez-Beltran A. Histologic grading of urothelial carcinoma: a reappraisal. Hum Pathol 2012;43(12): 2097-2108. https://doi.org/10.1016/j.humpath.2012.01.008
- MacLennan GT, Kirkali Z, Cheng L. Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol 2007;51(4): 889-897. https://doi.org/10.1016/j.eururo.2006.10.037
- Kirkali Z, Chan T, Manoharan M, Algaba F, Busch C, Cheng L, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology 2005;66(6 Suppl 1):4-34. https://doi.org/10.1016/j.urology.2005.07.062
- Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Comperat E, et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013. Eur Urol 2013;64(4):639-653. https://doi.org/10.1016/j.eururo.2013.06.003
- Bobinski J, Lipinski M. EORTC risk tables--a new diagnostic tool in urology. Pol Merkur Lekarski 2009;27(162):524-528 (Polish).
- Barton MK. High morbidity and mortality found for high-risk, non-muscle-invasive bladder cancer. CA Cancer J Clin 2013; 63(6):371-372. https://doi.org/10.3322/caac.21201
- Snyder C, Harlan L, Knopf K, Potosky A, Kaplan R. Patterns of care for the treatment of bladder cancer. J Urol 2003;169(5):1697-1701. https://doi.org/10.1097/01.ju.0000056727.30546.b7
- Hollenbeck BK, Dunn RL, Ye Z, Hollingsworth JM, Lee CT, Birkmeyer JD. Racial differences in treatment and outcomes among patients with early stage bladder cancer. Cancer 2010;116(1): 50-56. https://doi.org/10.1002/cncr.24701
- Underwood W 3rd, Dunn RL, Williams C, Lee CT. Gender and geographic influence on the racial disparity in bladder cancer mortality in the US. J Am Coll Surg 2006;202(2):284-290. https://doi.org/10.1016/j.jamcollsurg.2005.09.009
- Seo KW, Kim BH, Park CH, Kim CI, Chang HS. The efficacy of the EORTC scoring system and risk tables for the prediction of recurrence and progression of non-muscle-invasive bladder cancer after intravesical bacillus calmette-guerin instillation. Korean J Urol 2010;51(3):165-170. https://doi.org/10.4111/kju.2010.51.3.165
- Millan-Rodriguez F, Chechile-Toniolo G, Salvador-Bayarri J, Palou J, Vicente-Rodriguez J. Multivariate analysis of the prognostic factors of primary superficial bladder cancer. J Urol 2000; 163(1):73-78. https://doi.org/10.1016/S0022-5347(05)67975-X
- National Cancer Institute. Number of persons by race and Hispanic ethnicity for SEER participants (2010 census data 1) [cited 2018 May 17]. Available from: https://seer.cancer.gov/registries/data.html.
- National Cancer Institute. SEER program coding and staging manual 2016; 2016 [cited 2018 May 17]. Available from: https:// seer.cancer.gov/archive/manuals/2016/SPCSM_2016_maindoc.pdf.
- National Cancer Institute. Site recode ICD-O-3 (1/27/2003) definition [cited 2018 May 17]. Available from: https://seer.cancer.gov/siterecode/icdo3_d01272003/.
- National Cancer Institute. AJCC cancer staging [cited 2018 May 17]. Available from: https://seer.cancer.gov/seerstat/variables/seer/ajcc-stage/.
피인용 문헌
- Back pain following instillations of BCG for superficial bladder cancer is not a reactive complication: review of 30 Mycobacterium bovis BCG vertebral osteomyelitis cases vol.38, pp.6, 2018, https://doi.org/10.1007/s10067-019-04500-w
- Does Health Insurance Modify the Association Between Race and Cancer-Specific Survival in Patients with Urinary Bladder Malignancy in the U.S.? vol.16, pp.18, 2019, https://doi.org/10.3390/ijerph16183393
- Marital Status and Prognostic Nomogram for Bladder Cancer With Distant Metastasis: A SEER-Based Study vol.10, pp.None, 2020, https://doi.org/10.3389/fonc.2020.586458
- Non-Muscular Invasive Bladder Cancer: Re-envisioning Therapeutic Journey from Traditional to Regenerative Interventions vol.12, pp.3, 2018, https://doi.org/10.14336/ad.2020.1109
- Effect of Intravesical Chemotherapy on the Survival of Patients with Non-Muscle-Invasive Bladder Cancer Undergoing Transurethral Resection: A Retrospective Cohort Study Among Older Adults vol.14, pp.1, 2018, https://doi.org/10.2174/1874303x02114010020
- Comparison of survival in elderly patients treated with uretero-cutaneostomy or ileal conduit after radical cystectomy vol.21, pp.1, 2018, https://doi.org/10.1186/s12877-020-01861-9